Molecular mechanisms orchestrating intratumoral heterogeneity in Kras-driven carcinomas

被引：0
|
作者：
Azimi, Roxana
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2403
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2403
引用
收藏
页数：3
相关论文
共 50 条
  • [21] A synergistic combination therapy for KRAS-driven cancers
    Yang, Z.
    Liang, S-Q.
    Peng, R-W.
    Schmid, R. A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S706 - S706
  • [22] Phenotypic Intratumoral Heterogeneity of Endometrial Carcinomas
    Silva, Catia
    Pires-Luis, Ana S.
    Rocha, Eduardo
    Bartosch, Carla
    Lopes, Jose M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2018, 37 (02) : 154 - 166
  • [23] Intratumoral genetic heterogeneity of breast carcinomas
    Petersen, M. B.
    Laenkholm, A.-V
    Pallisgaard, N.
    Vach, W.
    Knoop, A.
    Bak, M.
    Ditzel, H. J.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2007, 22 (01): : 78 - 78
  • [24] Immunoprevention of KRAS-driven lung adenocarcinoma by a multi-peptide KRAS vaccine
    Pan, Jing
    Zhang, Qi
    Sei, Shizuko
    Shoemaker, Robert H.
    Lubet, Ronald A.
    Wang, Yian
    You, Ming
    CANCER RESEARCH, 2017, 77
  • [25] The ERBB network facilitates KRas-driven lung tumorigenesis
    Kruspig, Bjorn
    Monteverde, Tiziana
    Neidler, Sarah
    Hock, Andreas
    Kerr, Emma
    Nixon, Colin
    Clark, William
    Hedley, Ann
    Dick, Craig
    Vousden, Karen
    Martins, Carla
    Murphy, Daniel
    CLINICAL & EXPERIMENTAL METASTASIS, 2017, 34 (08) : 508 - 508
  • [26] Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
    Pan, Jing
    Zhang, Qi
    Sei, Shizuko
    Shoemaker, Robert H.
    Lubet, Ronald A.
    Wang, Yian
    You, Ming
    ONCOTARGET, 2017, 8 (47) : 82689 - 82699
  • [27] The ERBB network facilitates KRAS-driven lung tumorigenesis
    Kruspig, Bjorn
    Monteverde, Tiziana
    Neidler, Sarah
    Hock, Andreas
    Kerr, Emma
    Nixon, Colin
    Clark, William
    Hedley, Ann
    Laing, Sarah
    Coffelt, Seth B.
    Le Quesne, John
    Dick, Craig
    Vousden, Karen
    Martins, Carla P.
    Murphy, Daniel J.
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (446)
  • [28] A one-two punch for KRAS-driven cancer
    Megan Cully
    Nature Reviews Drug Discovery, 2015, 14 : 600 - 600
  • [29] Role of downstream effectors in Kras-driven myeloproliferative disease
    Shieh, Angell C.
    Shannon, Kevin M.
    BLOOD, 2007, 110 (11) : 483A - 483A
  • [30] A requirement for FADD and its phosphorylation for KRAS-driven oncogenesis
    Bowman, Brittany M.
    Galban, Stefanie
    Hoff, Benjamin A.
    Heist, Kevin A.
    Boes, Jennifer L.
    Galban, Craig J.
    Patel, Rajiv M.
    Zhang, Jianke
    Ross, Brian D.
    Rehemtulla, Alnawaz
    CANCER RESEARCH, 2014, 74 (19)
12345